Asp isotopes provides business updates

Washington, oct. 13, 2025 (globe newswire) -- asp isotopes inc. nasdaq: aspi ("asp isotopes” or the “company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today provided a business development update, including a supply agreement for the largest quantity of enriched silicon-28 received by the company to date and a strategic acquisition of a radiopharmacy in the united states to complement and expand the operations of pet labs pharmaceuticals (pty) ltd (“pet labs”), the company's south african radiopharmaceutical operations company, dedicated to nuclear medicine and the science of radiopharmaceutical production.
ASPI Ratings Summary
ASPI Quant Ranking